| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc408585f6863d7865c90ab9a4632135 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
| filingDate |
1983-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1987-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_627615c80954a51525265f81025a3a45 |
| publicationDate |
1987-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4642293-A |
| titleOfInvention |
Novel hybridoma cell line producing monoclonal antibodies against laminin and a process for the production thereof |
| abstract |
The invention relates to a novel hybridoma continuous cell line that produces a monoclonal antibody of the IgG type to the glycoprotein GP-2, a subunit of the basement membrane component laminin. The hybridoma cell line is formed from a spleen cell from a Lewis rat, which has been immunized with a basement membrane antigen, fused with a mouse myeloma cell. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5211657-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106749536-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5175251-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106749536-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5019087-A |
| priorityDate |
1983-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |